Editas Medicine (EDIT) Payables: 2015-2025
Historic Payables for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to $3.2 million.
- Editas Medicine's Payables fell 74.68% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.8 million, marking a year-over-year decrease of 50.95%. This contributed to the annual value of $5.5 million for FY2024, which is 33.57% down from last year.
- Latest data reveals that Editas Medicine reported Payables of $3.2 million as of Q3 2025, which was down 52.95% from $6.7 million recorded in Q2 2025.
- Editas Medicine's Payables' 5-year high stood at $13.8 million during Q2 2024, with a 5-year trough of $3.2 million in Q3 2025.
- For the 3-year period, Editas Medicine's Payables averaged around $8.3 million, with its median value being $8.1 million (2023).
- Its Payables has fluctuated over the past 5 years, first spiked by 100.94% in 2022, then slumped by 74.68% in 2025.
- Quarterly analysis of 5 years shows Editas Medicine's Payables stood at $5.0 million in 2021, then soared by 88.34% to $9.5 million in 2022, then decreased by 13.06% to $8.3 million in 2023, then slumped by 33.57% to $5.5 million in 2024, then slumped by 74.68% to $3.2 million in 2025.
- Its Payables stands at $3.2 million for Q3 2025, versus $6.7 million for Q2 2025 and $5.5 million for Q1 2025.